Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus butorphanol for ICU analgesia and sedation
ChiCTR1900026378Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and butorphanol in critical illness, pain and agitation (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: RASS score and CPOT score. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
critical illnesspainagitation
Beyond the preview
Go deeper on ChiCTR1900026378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026378.